Business Context and Reporting Period
This Form 8-K Current Report was filed by Metagenomi Therapeutics, Inc. (formerly Metagenomi, Inc.) on January 12, 2026. The filing documents a corporate name change effective at 12:01 a.m. Pacific Time on January 12, 2026, approved by the Board of Directors under Delaware law without a stockholder vote. The Company remains incorporated in Delaware and its common stock continues to trade on the Nasdaq Global Select Market under the symbol "MGX" with no change to its CUSIP number.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial statements or performance data.
Material Changes
- Corporate Name: Changed from "Metagenomi, Inc." to "Metagenomi Therapeutics, Inc."
- Governance Documents: The Amended and Restated Certificate of Incorporation and Bylaws were amended solely to reflect the new name.
- Stockholder Rights: The filing explicitly states that the name change does not affect the rights of the Company's stockholders.
Guidance, Outlook, and Risks
The Company issued a press release and a corporate presentation on January 12, 2026, announcing the name change and providing "additional business updates." However, the text of this Form 8-K does not detail specific guidance, outlook figures, risks, contingencies, or unusual items contained within those exhibits. The information in the press release and presentation is furnished but not deemed "filed" for purposes of Section 18 of the Exchange Act.
Key Facts for Investor Verification
- Verify the new corporate name "Metagenomi Therapeutics, Inc." in future filings and market data.
- Confirm that the trading symbol "MGX" and CUSIP number remain unchanged.
- Review the attached Press Release (Exhibit 99.1) and Corporate Presentation (Exhibit 99.2) for the "additional business updates" referenced but not detailed in this summary.
- Note that no stockholder vote was required for this name change.